Association of Serum Selenium Levels with the Response to Erythropoiesis-Stimulating Agents in Maintenance Hemodialysis Patients

被引：0
|
作者：
Yasukawa, Minoru [1 ]
Arai, Shigeyuki [1 ]
Nagura, Michito [1 ]
Hirohama, Daigoro [1 ]
Yamazaki, Osamu [1 ]
Tamura, Yoshifuru [1 ]
Fujigaki, Yoshihide [1 ]
Shibata, Shigeru [1 ]
机构：
[1] Teikyo Daigaku Igakubu Daigakuin Igaku Kenkyuka, Itabashi Ku, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1744
引用
收藏
页码：540 / 541
页数：2
相关论文
共 50 条
  • [31] BASAL HEMOGLOBIN PRODUCTION AND REQUIRED DOSE OF ERYTHROPOIESIS-STIMULATING AGENTS IN HEMODIALYSIS PATIENTS WITH ANEMIA
    Kuji, Tadashi
    Kaneda, Tomoko
    Nishihara, Masahiro
    Shibata, Kazuhiko
    Satta, Hidehisa
    Imoto, Kiyotaka
    Kawata, Sei-ichi
    Koguchi, Naoaki
    Fujikawa, Tetsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 463 - 463
  • [32] Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia
    Maruyama, Takashi
    Higuchi, Terumi
    Yamazaki, Toshio
    Okawa, Erina
    Ando, Hideyuki
    Oikawa, Osamu
    Inoshita, Atsushi
    Okada, Kazuyoshi
    Abe, Masanori
    CARDIORENAL MEDICINE, 2017, 7 (03) : 188 - 197
  • [33] Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients
    Gianni Biolo
    Gianfranco Guarnieri
    Rocco Barazzoni
    Giovanni Panzetta
    Clinical and Experimental Medicine, 2011, 11 : 181 - 187
  • [34] Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients
    Biolo, Gianni
    Guarnieri, Gianfranco
    Barazzoni, Rocco
    Panzetta, Giovanni
    CLINICAL AND EXPERIMENTAL MEDICINE, 2011, 11 (03) : 181 - 187
  • [35] Sufficient liver erythropoietin synthesis is induced in hemodialysis patients not requiring erythropoiesis-stimulating agents
    Yanagawa, Takamoto
    Hirayama, Aki
    Osada, Kayo
    Kuno, Akihiro
    Takahashi, Satoru
    CLINICAL NEPHROLOGY, 2022, 98 (03) : 167 - 170
  • [36] Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients
    Meaney, Calvin J.
    Karas, Spinel
    Robinson, Ben
    Gaesser, Jamie
    Forrest, Alan
    Krzyzanski, Wojciech
    Panesar, Mandip
    Rao, Gauri G.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03): : 418 - 426
  • [37] Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis
    Onuma, Shoko
    Honda, Hirokazu
    Kobayashi, Yasuna
    Yamamoto, Toshinori
    Michihata, Tetsuo
    Shibagaki, Keigo
    Yuza, Toshitaka
    Hirao, Keiichi
    Tomosugi, Naohisa
    Shibata, Takanori
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (06) : 582 - 589
  • [38] Trends in use of erythropoiesis-stimulating agents and blood transfusions in US hemodialysis patients with cancer
    Butler, Anne M.
    Kshirsagar, Abhijit V.
    Olshan, Andrew F.
    Nielsen, Matthew E.
    Wheeler, Stephanie B.
    Brookhart, M. Alan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 141 - 142
  • [39] RESPONSIVENESS TO ERYTHROPOIESIS-STIMULATING AGENTS IN PREVALENT HEMODIALYSIS PATIENTS WITH CANCER; MULTICENTER SURVEILLANCE IN JAPAN
    Matsubara, Takeshi
    Kondo, Naoya
    Funakoshi, Taro
    Horimatsu, Takahiro
    Muto, Manabu
    Yanagita, Motoko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [40] Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level
    Sanz Ortiz, Jaime
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (08): : 486 - 492
12345